Frélii, Inc. Share Price

FRLI

US3570511010

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 12:52:04 14/07/2026 am IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-

17/20/17	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
09/20/09	Frélii, Inc. announced that it has received $0.203 million in funding	CI

Frelii, Inc. provides Web-based nutrition and fitness programs based on usersâ€™ genetic data. The Company provides users personalized, deoxyribonucleic acid (DNA)-based diet and nutrition plans and identifies usersâ€™ health risks. Users can upload their raw genetic data by logging into their 23andMe profile and the Companyâ€™s site uploads that data for use by its artificial intelligence (AI)-based algorithm. Its products include KDIR, EZV-200, BLDB Tonic, Keotone-CoCoa and CTV. The Company provides tools, which includes personalized cookbook, meal planning, shopping lists, supplement packages and video workouts. It provides Navii, which is computer learning-based algorithm generates insight about individual genetic health risks, and assists health providers to identify and treat various health concerns. Its wellness plans feature nutrition and fitness plans, supplement recommendations, downloadable menus, recipes, and shopping lists, and virtual personal training.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume

Delayed Quote OTC Markets

More quotes

Stock Market
Stocks
FRLI Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	1.18Cr 1.04Cr 96.19L 88.32L 1.66Cr 113.58Cr 1.69Cr 11Cr 4.46Cr 56Cr 4.42Cr 4.32Cr 192.67Cr	P/E 2017	21.4x	P/E 2018	-12.5x
Enterprise Value	1.17Cr 1.03Cr 95.71L 87.88L 1.65Cr 113.02Cr 1.68Cr 11Cr 4.44Cr 55Cr 4.39Cr 4.3Cr 191.71Cr	EV / Sales 2017	-	EV / Sales 2018	2,16,76,35,443x
Free-Float	100%	Yield 2017 *	-	Yield 2018	-

17/20/17	Frélii, Inc. cancelled the acquisition of 25% shares of Genecor AI Inc. from Helix Investment Partners LLC.	CI
09/20/09	Frélii, Inc. announced that it has received $0.203 million in funding	CI
23/19/23	Frélii, Inc. entered into share purchase agreement to acquire 25% shares of Genecor AI Inc. for $0.94 million from Helix Investment Partners LLC.	CI
15/19/15	Frélii, Inc. announced that it has received $0.154 million in funding	CI
14/19/14	Frélii, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	CI
15/19/15	Frélii, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	CI
16/19/16	Frelii, Inc. Announces Resignation of Leslie Norris as Chief Operating Officer; Opens Its First Wholly Owned Subsidiary, Frelii Canada Inc. in Mississauga, Ontario, Canada	CI
10/19/10	Frélii, Inc. Inks Agreement with Orn Health Inc. to Support Healthcare Franchisee Partners Incorporating Pharmacogentics Into Patient Treatment	CI
23/19/23	Frelii Inc. Announces Executive Changes	CI
20/19/20	Frélii, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	CI
01/19/01	Frélii, Inc. Signs Contract and Licensing Agreement with Optivida Health	CI
16/19/16	Frélii, Inc. Reports Earnings Results for the Full Year Ended December 31, 2018	CI
13/19/13	Frélii, Inc. Announces Address Change	CI

Current year	0		0
1 year	0		0
3 years	0		0.04
5 years	0		0.04
10 years	0		10

Manager	Title	Age	Since
Ian Jenkins CEO	Chief Executive Officer	42	05/04/2017
Jayson Uffens CTO	Chief Tech/Sci/R&D Officer	51	15/05/2018
Hans Jenkins CTO	Chief Tech/Sci/R&D Officer	49	27/03/2018

Director	Title	Age	Since
Ian Jenkins BRD	Director/Board Member	42	05/04/2017
Tarek Mango BRD	Director/Board Member	55	01/01/2018
Hans Jenkins BRD	Director/Board Member	49	27/03/2018

Frélii, Inc. Share Price

Stocks

FRLI

US3570511010

Advanced Medical Equipment & Technology

Valuation: Frélii, Inc.

Chart: Frélii, Inc.

Latest news : Frélii, Inc.

Course Extremes

Managers and Directors: Frélii, Inc.

Medical Software & Technology Services

Financials

Company Profile

Quotes

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FRÉLII, INC.	0.00%	0.00%	-	-	58
VEEVA SYSTEMS INC.	+3.71%	-4.68%	-36.05%	-5.45%	3.03TCr
PRO MEDICUS LIMITED	-1.42%	-14.59%	-50.04%	+138.50%	1.17TCr
SECTRA AB	+1.76%	-3.42%	-27.38%	+57.74%	527.99Cr
HEARTFLOW, INC.	-1.99%	-3.05%	-	-	208.01Cr
OMNICELL, INC.	+2.86%	-10.62%	+45.75%	-34.09%	186.46Cr
GENERATE BIOMEDICINES, INC.	-3.11%	-1.18%	-	-	171.78Cr
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-3.12%	-3.55%	-39.08%	-	102.73Cr
ARBUTUS BIOPHARMA CORPORATION	-2.01%	-3.95%	+35.19%	+102.78%	87Cr
B-SOFT CO.,LTD.	-4.53%	-4.82%	-44.46%	-57.70%	72Cr
Average	-0.79%	-5.04%	-16.58%	+33.63%	554.87Cr
Weighted average by Cap.	+1.67%	-6.65%	-34.36%	+34.36%

	2017	2018
Net sales	-	0.04 0.03 0.03 0.03 0.05 3.47 0.05 0.35 0.14 1.7 0.13 0.13 5.89
Net income	6L 5L 5L 4L 8L 5.75Cr 9L 57.83L 22.58L 2.82Cr 22.35L 21.87L 9.75Cr	-55.5L -48.83L -45.38L -41.67L -78.21L -54Cr -79.52L -5.39Cr -2.1Cr -26Cr -2.08Cr -2.04Cr -91Cr
Net Debt	37.06T 32.61T 30.31T 27.83T 52.23T 35.79L 53.11T 4L 1L 17.54L 1L 1L 60.71L	-58.56T -51.52T -47.88T -43.97T -82.52T -56.54L -83.91T -6L -2L -27.72L -2L -2L -95.91L